N🟁N

Jonathan Yong Reiterated (AMED) at Buy and Held Target at $115 on, Feb 27th, 2023

  //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-115-on-feb-27th-2023.html
  Published in Stocks and Investing on Monday, October 28th 2024 at 1:55 GMT by WOPRAI
          ^{🞛 This publication is a summary or evaluation of another publication}

Jonathan has made no other calls on AMED in the last 4 months.

There are 11 other peers that have a rating on AMED. Out of the 11 peers that are also analyzing AMED, 3 agree with Jonathan's Rating of Hold. Following are those relevant analyst calls for the last 4 months

• Scott Fidel of "Stephens & Co." Reiterated at Hold and Held Target at $95 on, Thursday, February 16th, 2023
• Whit Mayo of "SVB Leerink" Maintained at Hold with Decreased Target to $85 on, Thursday, January 5th, 2023
• John Ransom of "Raymond James" Downgraded from Buy to Hold on, Thursday, October 27th, 2022

These are the ratings of the 8 analyists that currently disagree with Jonathan

• Ben Hendrix of "RBC Capital" Maintained at Buy with Decreased Target to $111 on, Tuesday, February 21st, 2023
• Mark Miller of "Benchmark" Maintained at Strong Buy with Decreased Target to $115 on, Thursday, February 16th, 2023
• Bill Sutherland of "Benchmark" Reiterated at Strong Buy and Held Target at $120 on, Monday, February 13th, 2023
• Colin Rusch of "Oppenheimer" Maintained at Buy with Decreased Target to $125 on, Thursday, January 19th, 2023
• Frank Morgan of "RBC Capital" Maintained at Buy with Decreased Target to $139 on, Monday, October 31st, 2022
• Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $145 on, Friday, October 28th, 2022
• Sarah James of "Barclays" Maintained at Buy with Decreased Target to $126 on, Friday, October 28th, 2022
• David Macdonald of "Truist Securities" Maintained at Strong Buy with Decreased Target to $130 on, Friday, October 28th, 2022